CIK 0001070081 · Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043416587
- Phone
- 9082227000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,752,145
- in 10 filings, $7.8M under 10b5-1 plans
Net −$7,752,145. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-06 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −822 | $68.91 | $57K | 106,655 |
| 2026-04-06 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −1,443 | $69.75 | $101K | 105,212 |
| 2026-04-06 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,265 | 6,798 | ||
| 2026-04-02 | Golden Lee Scott EVP & CHIEF MEDICAL OFFICER | Sale 10b5-1 | −829 | $67.99 | $56K | 79,115 |
| 2026-04-01 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −39,393 | $68.89 | $2.7M | 72,747 |
| 2026-04-01 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −12,530 | $69.50 | $871K | 60,217 |
| 2026-04-01 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −80 | $70.30 | $6K | 60,137 |
| 2026-03-24 | Chutter Jessica Caroline Director | Grant or award 10b5-1 | +4,000 | 4,000 | ||
| 2026-03-24 | Chutter Jessica Caroline Director | Grant or award 10b5-1 | +3,333 | 7,333 | ||
| 2026-03-24 | Chutter Jessica Caroline Director | Grant or award · Stock Option (Right to Buy) 10b5-1 | +3,475 | 3,475 | ||
| 2026-03-24 | Chutter Jessica Caroline Director | Grant or award · Stock Option (Right to Buy) 10b5-1 | +2,896 | 2,896 | ||
| 2026-03-12 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −2,662 | $64.08 | $171K | 396,920 |
| 2026-03-11 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Grant or award 10b5-1 | +12,500 | 399,582 | ||
| 2026-03-10 | Okey Stephanie Director | Option exercise 10b5-1 | +1,167 | $33.63 | $39K | 9,167 |
| 2026-03-10 | Okey Stephanie Director | Sale 10b5-1 | −1,167 | $70.00 | $82K | 8,000 |
| 2026-03-10 | Okey Stephanie Director | Option exercise 10b5-1 | +14,000 | $33.63 | $471K | 22,000 |
| 2026-03-10 | Okey Stephanie Director | Sale 10b5-1 | −14,000 | $70.00 | $980K | 8,000 |
| 2026-03-10 | Okey Stephanie Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,167 | 0 | ||
| 2026-03-10 | Okey Stephanie Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −14,000 | 0 | ||
| 2026-03-05 | Okey Stephanie Director | Sale 10b5-1 | −6,333 | $63.38 | $401K | 8,000 |
Page 8 of 25 · 493 trades